Christopher Bowman
Concepts (382)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymers | 60 | 2024 | 499 | 8.790 |
Why?
| | Composite Resins | 29 | 2021 | 106 | 7.740 |
Why?
| | Sulfhydryl Compounds | 27 | 2021 | 189 | 7.290 |
Why?
| | Polymerization | 25 | 2024 | 130 | 4.540 |
Why?
| | Polyethylene Glycols | 41 | 2025 | 655 | 3.900 |
Why?
| | Dental Materials | 16 | 2024 | 56 | 3.720 |
Why?
| | Methacrylates | 20 | 2021 | 119 | 3.680 |
Why?
| | Polymethacrylic Acids | 22 | 2021 | 61 | 3.530 |
Why?
| | Azides | 10 | 2022 | 47 | 2.900 |
Why?
| | Cycloaddition Reaction | 10 | 2021 | 29 | 2.540 |
Why?
| | Hydrogels | 20 | 2025 | 700 | 2.460 |
Why?
| | Click Chemistry | 7 | 2021 | 53 | 2.300 |
Why?
| | Materials Testing | 32 | 2024 | 354 | 2.280 |
Why?
| | Alkynes | 9 | 2022 | 66 | 2.280 |
Why?
| | Copper | 7 | 2021 | 113 | 2.200 |
Why?
| | DNA | 11 | 2021 | 1464 | 2.090 |
Why?
| | Esters | 5 | 2025 | 78 | 2.080 |
Why?
| | Photochemical Processes | 13 | 2024 | 108 | 2.010 |
Why?
| | Allyl Compounds | 7 | 2014 | 26 | 1.950 |
Why?
| | Nucleic Acids | 5 | 2021 | 72 | 1.860 |
Why?
| | Light | 19 | 2020 | 411 | 1.790 |
Why?
| | Oligonucleotides | 5 | 2020 | 151 | 1.760 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 15 | 2021 | 53 | 1.720 |
Why?
| | Biocompatible Materials | 16 | 2023 | 435 | 1.610 |
Why?
| | Stress, Mechanical | 22 | 2019 | 494 | 1.550 |
Why?
| | Acrylates | 10 | 2014 | 48 | 1.440 |
Why?
| | Pliability | 15 | 2019 | 48 | 1.400 |
Why?
| | Photochemistry | 13 | 2021 | 134 | 1.350 |
Why?
| | Thymine | 2 | 2020 | 17 | 1.230 |
Why?
| | Dental Restoration, Permanent | 6 | 2018 | 43 | 1.190 |
Why?
| | Surface Properties | 18 | 2020 | 410 | 1.160 |
Why?
| | Glucose Oxidase | 5 | 2012 | 25 | 1.130 |
Why?
| | Dental Stress Analysis | 8 | 2012 | 24 | 1.130 |
Why?
| | Phosphatidylcholines | 2 | 2019 | 131 | 1.080 |
Why?
| | Nanoparticles | 7 | 2019 | 520 | 1.070 |
Why?
| | Molecular Structure | 18 | 2018 | 501 | 1.000 |
Why?
| | Kinetics | 20 | 2019 | 1629 | 0.970 |
Why?
| | Silicon Dioxide | 3 | 2020 | 121 | 0.970 |
Why?
| | Microfluidic Analytical Techniques | 4 | 2012 | 81 | 0.930 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 13 | 2015 | 88 | 0.890 |
Why?
| | Carbonates | 1 | 2025 | 11 | 0.890 |
Why?
| | Resins, Synthetic | 2 | 2018 | 14 | 0.890 |
Why?
| | Nucleic Acid Hybridization | 4 | 2020 | 187 | 0.890 |
Why?
| | Sulfides | 3 | 2012 | 92 | 0.890 |
Why?
| | Carbamates | 1 | 2025 | 52 | 0.860 |
Why?
| | Glass | 3 | 2014 | 46 | 0.850 |
Why?
| | Triazines | 4 | 2010 | 49 | 0.840 |
Why?
| | Printing, Three-Dimensional | 2 | 2024 | 96 | 0.810 |
Why?
| | 3-Mercaptopropionic Acid | 5 | 2014 | 6 | 0.800 |
Why?
| | Sulfhydryl Reagents | 2 | 2014 | 12 | 0.790 |
Why?
| | Propylene Glycols | 5 | 2014 | 27 | 0.780 |
Why?
| | Triazoles | 3 | 2019 | 184 | 0.770 |
Why?
| | Antigens | 5 | 2012 | 347 | 0.740 |
Why?
| | Elastic Modulus | 8 | 2016 | 121 | 0.720 |
Why?
| | Water | 6 | 2021 | 469 | 0.710 |
Why?
| | Temperature | 9 | 2024 | 679 | 0.690 |
Why?
| | Tetraphenylborate | 1 | 2020 | 1 | 0.670 |
Why?
| | Catalysis | 6 | 2021 | 322 | 0.650 |
Why?
| | Norbornanes | 2 | 2010 | 15 | 0.640 |
Why?
| | Chlorella vulgaris | 1 | 2020 | 5 | 0.630 |
Why?
| | Polyelectrolytes | 1 | 2020 | 15 | 0.630 |
Why?
| | Ethers | 3 | 2010 | 19 | 0.620 |
Why?
| | Mechanical Phenomena | 4 | 2015 | 80 | 0.610 |
Why?
| | Elastomers | 3 | 2021 | 31 | 0.600 |
Why?
| | Nitro Compounds | 1 | 2019 | 8 | 0.600 |
Why?
| | Light-Curing of Dental Adhesives | 4 | 2012 | 10 | 0.590 |
Why?
| | Benzopyrans | 1 | 2019 | 30 | 0.590 |
Why?
| | Unilamellar Liposomes | 1 | 2018 | 8 | 0.570 |
Why?
| | Rheology | 1 | 2019 | 94 | 0.570 |
Why?
| | Liquid Crystals | 1 | 2018 | 30 | 0.550 |
Why?
| | Lactones | 1 | 2018 | 58 | 0.550 |
Why?
| | Hydroxides | 1 | 2017 | 26 | 0.530 |
Why?
| | DNA, Single-Stranded | 1 | 2018 | 119 | 0.520 |
Why?
| | Cross-Linking Reagents | 9 | 2025 | 207 | 0.520 |
Why?
| | Biofilms | 2 | 2018 | 278 | 0.520 |
Why?
| | Liposomes | 1 | 2019 | 250 | 0.510 |
Why?
| | Ethylene Glycols | 4 | 2005 | 17 | 0.500 |
Why?
| | Elasticity | 9 | 2018 | 184 | 0.500 |
Why?
| | Oxidation-Reduction | 5 | 2016 | 1087 | 0.480 |
Why?
| | Maleimides | 2 | 2013 | 21 | 0.480 |
Why?
| | Fluorescent Dyes | 4 | 2011 | 330 | 0.480 |
Why?
| | Furans | 2 | 2013 | 27 | 0.470 |
Why?
| | Delayed-Action Preparations | 2 | 2013 | 183 | 0.450 |
Why?
| | Eosine Yellowish-(YS) | 3 | 2011 | 10 | 0.440 |
Why?
| | Indoles | 1 | 2019 | 501 | 0.440 |
Why?
| | Streptavidin | 3 | 2011 | 15 | 0.440 |
Why?
| | Ascorbic Acid | 1 | 2016 | 180 | 0.440 |
Why?
| | RNA | 1 | 2021 | 940 | 0.440 |
Why?
| | Amines | 2 | 2013 | 40 | 0.430 |
Why?
| | Phosphines | 1 | 2014 | 18 | 0.420 |
Why?
| | Dental Impression Materials | 1 | 2014 | 3 | 0.420 |
Why?
| | Siloxanes | 1 | 2014 | 7 | 0.410 |
Why?
| | Sulfones | 1 | 2014 | 127 | 0.400 |
Why?
| | Acrylic Resins | 2 | 2025 | 45 | 0.380 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 4 | 2013 | 79 | 0.380 |
Why?
| | Nanostructures | 2 | 2011 | 117 | 0.370 |
Why?
| | Cyclooctanes | 2 | 2018 | 6 | 0.370 |
Why?
| | RNA, Messenger | 1 | 2020 | 2832 | 0.370 |
Why?
| | Biotin | 2 | 2009 | 32 | 0.370 |
Why?
| | Myoblasts | 4 | 2023 | 84 | 0.350 |
Why?
| | Antibodies | 3 | 2009 | 403 | 0.350 |
Why?
| | Models, Chemical | 6 | 2014 | 269 | 0.340 |
Why?
| | Phase Transition | 4 | 2019 | 26 | 0.340 |
Why?
| | Ultraviolet Rays | 7 | 2019 | 388 | 0.340 |
Why?
| | Osteogenesis | 1 | 2013 | 208 | 0.330 |
Why?
| | Engineering | 1 | 2011 | 30 | 0.330 |
Why?
| | Transition Temperature | 4 | 2014 | 29 | 0.330 |
Why?
| | Analysis of Variance | 6 | 2012 | 1311 | 0.320 |
Why?
| | Dexamethasone | 1 | 2013 | 372 | 0.320 |
Why?
| | Particle Size | 6 | 2021 | 411 | 0.320 |
Why?
| | Magnetics | 1 | 2010 | 48 | 0.320 |
Why?
| | Staining and Labeling | 1 | 2011 | 151 | 0.320 |
Why?
| | Hydrolysis | 3 | 2025 | 199 | 0.320 |
Why?
| | Dental Marginal Adaptation | 4 | 2012 | 10 | 0.310 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 370 | 0.310 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 758 | 0.310 |
Why?
| | Enzyme Assays | 1 | 2009 | 25 | 0.310 |
Why?
| | Iron | 1 | 2012 | 359 | 0.300 |
Why?
| | Biomedical Engineering | 2 | 2007 | 29 | 0.300 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2009 | 109 | 0.300 |
Why?
| | Tensile Strength | 6 | 2025 | 96 | 0.300 |
Why?
| | Nucleotides | 1 | 2010 | 128 | 0.300 |
Why?
| | Protein Array Analysis | 1 | 2009 | 56 | 0.290 |
Why?
| | Biosensing Techniques | 1 | 2011 | 139 | 0.290 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2008 | 39 | 0.290 |
Why?
| | Cartilage | 2 | 2002 | 198 | 0.290 |
Why?
| | Technology, Dental | 2 | 2005 | 5 | 0.280 |
Why?
| | Gene Amplification | 1 | 2008 | 121 | 0.280 |
Why?
| | Alkanes | 1 | 2007 | 14 | 0.270 |
Why?
| | Chemical Phenomena | 5 | 2010 | 81 | 0.260 |
Why?
| | Hardness | 4 | 2012 | 17 | 0.260 |
Why?
| | Nucleic Acid Conformation | 2 | 2020 | 726 | 0.260 |
Why?
| | Cell Differentiation | 3 | 2017 | 2050 | 0.250 |
Why?
| | Coated Materials, Biocompatible | 4 | 2011 | 65 | 0.250 |
Why?
| | Free Radicals | 3 | 2012 | 110 | 0.240 |
Why?
| | Gold | 2 | 2018 | 116 | 0.240 |
Why?
| | Dystocia | 1 | 2026 | 12 | 0.240 |
Why?
| | Cell Membrane | 1 | 2009 | 706 | 0.240 |
Why?
| | Phospholipids | 2 | 2018 | 213 | 0.230 |
Why?
| | Enzymes, Immobilized | 2 | 2019 | 30 | 0.230 |
Why?
| | Dental Casting Investment | 1 | 2024 | 1 | 0.210 |
Why?
| | Staphylococcus epidermidis | 3 | 2010 | 79 | 0.210 |
Why?
| | Endothelial Cells | 1 | 2011 | 870 | 0.210 |
Why?
| | Cell Line | 4 | 2025 | 2882 | 0.210 |
Why?
| | Vancomycin | 3 | 2010 | 93 | 0.210 |
Why?
| | Biophysics | 1 | 2004 | 74 | 0.210 |
Why?
| | Calorimetry | 1 | 2024 | 72 | 0.210 |
Why?
| | Photography | 1 | 2004 | 115 | 0.210 |
Why?
| | Crystallization | 1 | 2024 | 146 | 0.200 |
Why?
| | Models, Molecular | 3 | 2018 | 1619 | 0.200 |
Why?
| | Equipment Design | 1 | 2004 | 530 | 0.190 |
Why?
| | Immunologic Factors | 1 | 2025 | 255 | 0.190 |
Why?
| | Solubility | 3 | 2017 | 242 | 0.190 |
Why?
| | Humans | 29 | 2025 | 144957 | 0.180 |
Why?
| | Drug Carriers | 3 | 2019 | 130 | 0.180 |
Why?
| | Chemistry, Physical | 4 | 2005 | 39 | 0.180 |
Why?
| | Heptanes | 2 | 2012 | 3 | 0.170 |
Why?
| | Bridged Bicyclo Compounds | 2 | 2012 | 14 | 0.170 |
Why?
| | Polyesters | 2 | 2019 | 80 | 0.170 |
Why?
| | Resins, Plant | 1 | 2001 | 5 | 0.170 |
Why?
| | Printing | 1 | 2020 | 5 | 0.170 |
Why?
| | Sensitivity and Specificity | 4 | 2011 | 1990 | 0.170 |
Why?
| | Tissue Engineering | 2 | 2023 | 442 | 0.170 |
Why?
| | Endocytosis | 2 | 2020 | 168 | 0.160 |
Why?
| | Cyclization | 2 | 2011 | 22 | 0.160 |
Why?
| | Magnetic Resonance Spectroscopy | 6 | 2009 | 631 | 0.160 |
Why?
| | Osmolar Concentration | 1 | 2020 | 167 | 0.160 |
Why?
| | Flocculation | 1 | 2020 | 7 | 0.160 |
Why?
| | 3T3 Cells | 2 | 2018 | 156 | 0.160 |
Why?
| | Molecular Weight | 1 | 2020 | 327 | 0.160 |
Why?
| | Animals | 15 | 2026 | 38109 | 0.160 |
Why?
| | Color | 2 | 2011 | 81 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2017 | 531 | 0.150 |
Why?
| | Residential Treatment | 1 | 1999 | 31 | 0.150 |
Why?
| | Statistics, Nonparametric | 2 | 2010 | 427 | 0.150 |
Why?
| | Organoids | 1 | 2021 | 141 | 0.150 |
Why?
| | Time Factors | 6 | 2012 | 7183 | 0.150 |
Why?
| | Cytosine Deaminase | 1 | 2019 | 15 | 0.150 |
Why?
| | Pregnancy Complications | 1 | 2025 | 592 | 0.150 |
Why?
| | Health Services for the Aged | 1 | 1999 | 70 | 0.150 |
Why?
| | Luminescent Proteins | 1 | 2020 | 185 | 0.150 |
Why?
| | Aza Compounds | 1 | 2018 | 13 | 0.140 |
Why?
| | Prodrugs | 1 | 2019 | 52 | 0.140 |
Why?
| | Nanofibers | 1 | 2018 | 24 | 0.140 |
Why?
| | Streptococcus mutans | 1 | 2018 | 8 | 0.140 |
Why?
| | Lipid Bilayers | 1 | 2019 | 103 | 0.140 |
Why?
| | Nanotubes | 1 | 2018 | 48 | 0.140 |
Why?
| | Fourier Analysis | 1 | 2018 | 41 | 0.140 |
Why?
| | X-linked Nuclear Protein | 1 | 2017 | 8 | 0.140 |
Why?
| | Sulfonic Acids | 1 | 2017 | 17 | 0.130 |
Why?
| | Organelles | 1 | 2018 | 57 | 0.130 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2017 | 70 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2025 | 2499 | 0.130 |
Why?
| | Halogens | 2 | 2010 | 14 | 0.130 |
Why?
| | Mechanotransduction, Cellular | 1 | 2018 | 122 | 0.130 |
Why?
| | SOXB1 Transcription Factors | 1 | 2017 | 67 | 0.130 |
Why?
| | Escherichia coli Proteins | 1 | 2019 | 206 | 0.130 |
Why?
| | Nanotechnology | 2 | 2009 | 126 | 0.120 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 192 | 0.120 |
Why?
| | Thermodynamics | 1 | 2018 | 426 | 0.120 |
Why?
| | Ruthenium | 1 | 2016 | 34 | 0.120 |
Why?
| | Mice | 9 | 2023 | 18365 | 0.120 |
Why?
| | Adhesiveness | 1 | 2015 | 18 | 0.120 |
Why?
| | Luminescence | 1 | 2015 | 39 | 0.120 |
Why?
| | Sulfonamides | 1 | 2019 | 581 | 0.110 |
Why?
| | Gels | 3 | 2013 | 84 | 0.110 |
Why?
| | Organometallic Compounds | 1 | 2016 | 112 | 0.110 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 86 | 0.110 |
Why?
| | Proteins | 1 | 2021 | 1022 | 0.110 |
Why?
| | NIH 3T3 Cells | 3 | 2009 | 148 | 0.110 |
Why?
| | Kaolin | 1 | 2014 | 5 | 0.100 |
Why?
| | Hydrogen Bonding | 1 | 2014 | 169 | 0.100 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2014 | 140 | 0.100 |
Why?
| | Staphylococcal Infections | 2 | 2009 | 390 | 0.100 |
Why?
| | Hot Temperature | 2 | 2010 | 407 | 0.100 |
Why?
| | Spectrophotometry, Infrared | 2 | 2004 | 55 | 0.100 |
Why?
| | Aspergillus niger | 1 | 2012 | 10 | 0.090 |
Why?
| | Thiones | 1 | 2012 | 11 | 0.090 |
Why?
| | Ubiquitination | 1 | 2012 | 118 | 0.090 |
Why?
| | Immunoassay | 1 | 2012 | 109 | 0.090 |
Why?
| | Calorimetry, Differential Scanning | 2 | 2002 | 37 | 0.080 |
Why?
| | Mammals | 2 | 2023 | 293 | 0.080 |
Why?
| | Muscle Development | 1 | 2012 | 116 | 0.080 |
Why?
| | Biotinylation | 1 | 2011 | 37 | 0.080 |
Why?
| | Cell Survival | 3 | 2023 | 1098 | 0.080 |
Why?
| | Absorption | 1 | 2010 | 60 | 0.080 |
Why?
| | Computer Simulation | 2 | 2013 | 1026 | 0.080 |
Why?
| | DNA Primers | 2 | 2012 | 512 | 0.080 |
Why?
| | Hydrazines | 1 | 2011 | 37 | 0.080 |
Why?
| | Titanium | 2 | 2010 | 81 | 0.080 |
Why?
| | Photoinitiators, Dental | 1 | 2010 | 2 | 0.080 |
Why?
| | Chromium Compounds | 1 | 2010 | 2 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 168 | 0.080 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 375 | 0.080 |
Why?
| | Isocyanates | 1 | 2010 | 9 | 0.080 |
Why?
| | Viscosity | 3 | 2018 | 90 | 0.080 |
Why?
| | Dendrimers | 1 | 2010 | 20 | 0.080 |
Why?
| | Prosthesis-Related Infections | 2 | 2009 | 99 | 0.080 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2010 | 48 | 0.080 |
Why?
| | Solutions | 2 | 2014 | 167 | 0.080 |
Why?
| | Phosphinic Acids | 1 | 2009 | 8 | 0.080 |
Why?
| | Prostheses and Implants | 2 | 2009 | 141 | 0.080 |
Why?
| | Microscopy, Fluorescence | 2 | 2008 | 418 | 0.080 |
Why?
| | Ethanolamines | 1 | 2009 | 14 | 0.080 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2009 | 36 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1958 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1915 | 0.070 |
Why?
| | Optics and Photonics | 1 | 2009 | 41 | 0.070 |
Why?
| | False Negative Reactions | 1 | 2008 | 61 | 0.070 |
Why?
| | Photons | 1 | 2009 | 76 | 0.070 |
Why?
| | Amino Acids | 1 | 2013 | 522 | 0.070 |
Why?
| | Microfluidics | 2 | 2006 | 62 | 0.070 |
Why?
| | Tooth | 1 | 2009 | 45 | 0.070 |
Why?
| | Dye Dilution Technique | 1 | 2008 | 1 | 0.070 |
Why?
| | Forecasting | 1 | 2010 | 391 | 0.070 |
Why?
| | Barium Compounds | 1 | 2008 | 12 | 0.070 |
Why?
| | Orthomyxoviridae | 1 | 2008 | 40 | 0.070 |
Why?
| | Codon | 1 | 2008 | 94 | 0.070 |
Why?
| | Silanes | 1 | 2008 | 18 | 0.070 |
Why?
| | Binding, Competitive | 1 | 2008 | 193 | 0.070 |
Why?
| | Base Sequence | 2 | 2012 | 2191 | 0.070 |
Why?
| | ras Proteins | 1 | 2008 | 151 | 0.070 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 253 | 0.070 |
Why?
| | Morpholines | 1 | 2008 | 129 | 0.070 |
Why?
| | Models, Theoretical | 3 | 2006 | 582 | 0.070 |
Why?
| | Dental Caries | 1 | 2009 | 173 | 0.060 |
Why?
| | Buffers | 1 | 2007 | 55 | 0.060 |
Why?
| | Peptides | 1 | 2013 | 998 | 0.060 |
Why?
| | Diffusion | 2 | 2014 | 122 | 0.060 |
Why?
| | Glucose | 1 | 2012 | 1049 | 0.060 |
Why?
| | Fibroblasts | 2 | 2009 | 1034 | 0.060 |
Why?
| | Tomography, Optical Coherence | 1 | 2009 | 271 | 0.060 |
Why?
| | Oligopeptides | 1 | 2008 | 269 | 0.060 |
Why?
| | Protons | 1 | 2007 | 95 | 0.060 |
Why?
| | Histones | 1 | 2012 | 670 | 0.060 |
Why?
| | Animals, Laboratory | 1 | 2026 | 21 | 0.060 |
Why?
| | Rodentia | 1 | 2026 | 62 | 0.060 |
Why?
| | Vinyl Compounds | 1 | 2005 | 5 | 0.060 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1048 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2007 | 561 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 623 | 0.060 |
Why?
| | Dentistry, Operative | 1 | 2004 | 4 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2009 | 893 | 0.050 |
Why?
| | Molecular Conformation | 1 | 2005 | 148 | 0.050 |
Why?
| | Dental Bonding | 1 | 2004 | 28 | 0.050 |
Why?
| | Protein Engineering | 1 | 2005 | 122 | 0.050 |
Why?
| | Photolysis | 1 | 2025 | 94 | 0.050 |
Why?
| | Equipment Failure Analysis | 1 | 2004 | 128 | 0.050 |
Why?
| | Calibration | 1 | 2004 | 151 | 0.050 |
Why?
| | Immunomodulation | 1 | 2025 | 101 | 0.050 |
Why?
| | Xenon | 1 | 2003 | 7 | 0.050 |
Why?
| | Cattle | 2 | 2007 | 1000 | 0.050 |
Why?
| | Neoplasms | 1 | 2019 | 2884 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1786 | 0.050 |
Why?
| | Pregnancy | 2 | 2026 | 7191 | 0.050 |
Why?
| | Algorithms | 2 | 2001 | 1839 | 0.050 |
Why?
| | Proteomics | 1 | 2009 | 1195 | 0.050 |
Why?
| | Polyvinyl Alcohol | 1 | 2002 | 18 | 0.050 |
Why?
| | Models, Statistical | 1 | 2006 | 682 | 0.050 |
Why?
| | Somatomedins | 1 | 2002 | 28 | 0.050 |
Why?
| | Pregnancy Outcome | 1 | 2025 | 476 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2002 | 74 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2017 | 4155 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 1796 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3550 | 0.040 |
Why?
| | Isoelectric Point | 1 | 2021 | 23 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2147 | 0.040 |
Why?
| | Regression Analysis | 1 | 2003 | 1003 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2005 | 1095 | 0.040 |
Why?
| | Biomechanical Phenomena | 2 | 2002 | 842 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3415 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 2020 | 224 | 0.040 |
Why?
| | Flucytosine | 1 | 2019 | 10 | 0.040 |
Why?
| | Organizational Policy | 1 | 1999 | 76 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 479 | 0.040 |
Why?
| | Biodegradation, Environmental | 1 | 1999 | 87 | 0.040 |
Why?
| | United Kingdom | 1 | 1999 | 338 | 0.040 |
Why?
| | Phenylacetates | 1 | 2018 | 10 | 0.030 |
Why?
| | CCCTC-Binding Factor | 1 | 2017 | 12 | 0.030 |
Why?
| | Binding Sites | 1 | 2001 | 1331 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 1999 | 281 | 0.030 |
Why?
| | Rubber | 1 | 1996 | 7 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 369 | 0.030 |
Why?
| | Astrocytoma | 1 | 2017 | 129 | 0.030 |
Why?
| | Doxorubicin | 1 | 2019 | 397 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2017 | 309 | 0.030 |
Why?
| | Apoptosis | 2 | 2017 | 2430 | 0.030 |
Why?
| | Cell Adhesion | 2 | 2008 | 455 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 509 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 476 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2017 | 166 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2015 | 89 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3676 | 0.030 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2014 | 20 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 685 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 683 | 0.020 |
Why?
| | Pyridines | 1 | 2016 | 605 | 0.020 |
Why?
| | Transcriptional Elongation Factors | 1 | 2012 | 39 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2012 | 139 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2012 | 415 | 0.020 |
Why?
| | Methylation | 1 | 2012 | 242 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 341 | 0.020 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2011 | 20 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 132 | 0.020 |
Why?
| | Cell Physiological Phenomena | 1 | 2010 | 19 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 21 | 0.020 |
Why?
| | Bone Cements | 1 | 2010 | 39 | 0.020 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2012 | 214 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 389 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2012 | 193 | 0.020 |
Why?
| | Foreskin | 1 | 2009 | 5 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 983 | 0.020 |
Why?
| | Lithium | 1 | 2009 | 42 | 0.020 |
Why?
| | Down-Regulation | 1 | 2012 | 627 | 0.020 |
Why?
| | Acrylamides | 1 | 2009 | 70 | 0.020 |
Why?
| | Bacterial Adhesion | 1 | 2009 | 110 | 0.020 |
Why?
| | Microchemistry | 1 | 2008 | 19 | 0.020 |
Why?
| | Lasers | 1 | 2009 | 132 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2009 | 570 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2017 | 1322 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 371 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2009 | 249 | 0.020 |
Why?
| | Chromatin | 1 | 2012 | 561 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2007 | 131 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1173 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2010 | 316 | 0.020 |
Why?
| | Female | 2 | 2026 | 78376 | 0.020 |
Why?
| | Fluoresceins | 1 | 2007 | 48 | 0.020 |
Why?
| | Osmosis | 1 | 2006 | 20 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 906 | 0.020 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 50 | 0.020 |
Why?
| | Ligands | 1 | 2008 | 674 | 0.010 |
Why?
| | Glucagon | 1 | 2005 | 113 | 0.010 |
Why?
| | Cell Communication | 1 | 2007 | 324 | 0.010 |
Why?
| | Collagen | 1 | 2007 | 456 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 851 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2011 | 1982 | 0.010 |
Why?
| | Polyvinyls | 1 | 2002 | 20 | 0.010 |
Why?
| | Aged | 1 | 1999 | 25947 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2009 | 6434 | 0.010 |
Why?
| | Quality Control | 1 | 1996 | 163 | 0.010 |
Why?
| | Male | 1 | 2009 | 72406 | 0.000 |
Why?
|
|
Bowman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|